Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1516405

Cover Image

PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1516405

ePrescribing Market - By Product (Solutions {Integrated, Standalone}, Services), Delivery Mode (Web/Cloud-based, On-premises), Substances (Controlled, Non-controlled), Usage (Handheld, Computer-based), Specialties, End-use, Global Forecast (2024 - 2032)

PUBLISHED:
PAGES: 140 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 4850
PDF & Excel (Multi User License)
USD 5350
PDF & Excel (Enterprise User License)
USD 8350

Add to Cart

Global ePrescribing Market will observe a CAGR of 23.9% from 2024 to 2032, driven by the rise of large-scale corporate partnerships and alliances. This collaboration is crucial in the worldwide adoption of electronic prescribing systems. As healthcare providers and organizations seek to enhance patient safety, improve medication adherence, and streamline healthcare, e-prescribing solutions offer significant benefits.

For instance, in October 2023, FDB, a leading medical technology provider of accurate healthcare decisions, and Veradigm, known for its healthcare information and technology solutions, announced a partnership to launch the first Veradigm and Electronic Health Record (EHR) network to connect to the FDB Vela(TM) ePrescribing Network. Veradigm FDB will integrate the Vela ePrescribeng network with a range of solutions for users and partners.

Partnerships between technology companies, pharmaceutical companies, and healthcare providers facilitate the integration of e-prescribing with electronic health record (EHR) systems and telemedicine platforms. This integration improves collaboration and data exchange and ensures medication is prescribed accurately and effectively in health care. Additionally, a cross-platform agreement drives innovation in ePrescribing software, focusing on user-friendly interfaces, advanced decision support tools, and regulatory standards.

The overall ePrescribing industry is classified based on product, delivery mode, substances, usage, specialties, end-user, and region.

The ePrescribing market revenue from the services segment will register a commendable CAGR from 2024 to 2032. The functionality of e-prescribing is essential to streamline medication management, reduce prescribing errors, and improve overall health outcomes. Healthcare providers and organizations are adopting e-prescribing solutions to increase productivity, integrate with electronic health records (EHRs), and meet regulatory standards.

In addition, e-prescribing services offer advanced features such as real-time drug interaction alerts, drug analytics, and electronic prescriptions, which improve medication adherence and patient care, such as healthcare worldwide. As the transition to digital transformation continues, the demand for comprehensive e-scheduling services continues to grow. Providers will use these services to achieve operational efficiencies, reduce medication-related errors, and ultimately improve patient care.

The on-premises segment will witness an appreciable growth from 2024 to 2032. Campus e-prescribing systems allow healthcare providers to manage patient prescriptions in their systems, ensuring confidentiality and adherence to regulatory guidelines.

Health systems that seamlessly integrate these systems with electronic health records (EHRs) and existing practice management software provide resources that can be customized as needed. By providing on-site e-prescribing, healthcare organizations retain full data management and access control, which is critical to ensure patient privacy and compliance with industry-specific regulations. Whereas healthcare providers prioritize data security and performance management, on-site e-prescribing solutions are required to support effective prescription management and overall patient care.

Europe ePrescribing market will exhibit a notable CAGR from 2024 to 2032. E-prescribing plays an important role in improving medication safety, reducing prescribing errors, and increasing access to health care. European countries are increasingly adopting electronic health records (EHRs) and integrating ePrescribing functions to facilitate medication management in healthcare systems.

In addition, regulatory initiatives such as the European Commission's eHealth Action Plan and the Digital Single Market Strategy are encouraging the adoption of e-prescribing to achieve standardized health practices and improve patient outcomes. Health professionals in Europe are investing in advanced ePrescribing systems that provide features such as decision support tools, access to medication history, and electronic prescribing. As healthcare delivery evolves, the demand for comprehensive and interactive e-prescribing solutions continues to expand in Europe to support integrated and patient-centered care pathways.

Product Code: 8999

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates & calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360-degree synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Growing adoption of electronic health records (EHR)
      • 3.2.1.2 Favorable government policies and funding
      • 3.2.1.3 Increasing expenditure on healthcare
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Concern regarding security
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Porter's analysis
  • 3.6 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Competitive analysis of major market players
  • 4.4 Competitive positioning matrix
  • 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Million)

  • 5.1 Key trends
  • 5.2 Solutions
    • 5.2.1 Integrated solutions
    • 5.2.2 Standalone solutions
  • 5.3 Services
    • 5.3.1 Support
    • 5.3.2 Implementation
    • 5.3.3 Training
    • 5.3.4 Network

Chapter 6 Market Estimates and Forecast, By Delivery Mode, 2021 - 2032 ($ Million)

  • 6.1 Key trends
  • 6.2 Web/cloud-based
  • 6.3 On-premises

Chapter 7 Market Estimates and Forecast, By Substances, 2021 - 2032 ($ Million)

  • 7.1 Key trends
  • 7.2 Controlled substances
  • 7.3 Non-controlled substances

Chapter 8 Market Estimates and Forecast, By Usage, 2021 - 2032 ($ Million)

  • 8.1 Key trends
  • 8.2 Handheld
  • 8.3 Computer-based devices

Chapter 9 OMarket Estimates and Forecast, By Specialties, 2021 - 2032 ($ Million)

  • 9.1 Key trends
  • 9.2 Oncology
  • 9.3 Sports medicine
  • 9.4 Neurology
  • 9.5 Cardiology
  • 9.6 Other specialties

Chapter 10 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Million)

  • 10.1 Key trends
  • 10.2 Hospital
  • 10.3 Office-based physicians
  • 10.4 Pharmacy
  • 10.5 Other end-users

Chapter 11 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

  • 11.1 Key trends
  • 11.2 North America
    • 11.2.1 U.S.
    • 11.2.2 Canada
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 UK
    • 11.3.3 France
    • 11.3.4 Spain
    • 11.3.5 Italy
    • 11.3.6 Rest of Europe
  • 11.4 Asia Pacific
    • 11.4.1 Japan
    • 11.4.2 China
    • 11.4.3 India
    • 11.4.4 Australia
    • 11.4.5 Rest of Asia Pacific
  • 11.5 Latin America
    • 11.5.1 Brazil
    • 11.5.2 Mexico
    • 11.5.3 Rest of Latin America
  • 11.6 Middle East and Africa
    • 11.6.1 South Africa
    • 11.6.2 Saudi Arabia
    • 11.6.3 Rest of Middle East and Africa

Chapter 12 Company Profiles

  • 12.1 Allscripts Healthcare, LLC
  • 12.2 Athenahealth
  • 12.3 Change Healthcare
  • 12.4 DrFirst
  • 12.5 Epic Systems Corporation
  • 12.6 McKesson Corporation
  • 12.7 Networking Technology, Inc.
  • 12.8 NXGN Management, LLC
  • 12.9 Practice Fusion, Inc.
  • 12.10 Surescripts
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!